» Articles » PMID: 30872156

North American Clinical Management Guidelines for Hidradenitis Suppurativa: A Publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, Evaluation, and the Use of Complementary and Procedural Management

Abstract

Hidradenitis suppurativa is a chronic inflammatory disorder affecting hair follicles, with profoundly negative impact on patient quality of life. Evidence informing ideal evaluation and management of patients with hidradenitis suppurativa is still sparse in many areas, but it has grown substantially in the last decade. Part I of this evidence-based guideline is presented to support health care practitioners as they select optimal management strategies, including diagnostic testing, comorbidity screening, and both complementary and procedural treatment options. Recommendations and evidence grading based on the evidence available at the time of the review are provided.

Citing Articles

Microbial Colonization and Antibiotic Resistance Profiles in Chronic Wounds: A Comparative Study of Hidradenitis Suppurativa and Venous Ulcers.

Sandru F, Poenaru E, Stoleru S, Radu A, Roman A, Ionescu C Antibiotics (Basel). 2025; 14(1).

PMID: 39858339 PMC: 11759762. DOI: 10.3390/antibiotics14010053.


Management of hidradenitis suppurativa in the inpatient setting: a clinical guide.

Maskan Bermudez N, Elman S, Kirsner R, Lev-Tov H Arch Dermatol Res. 2025; 317(1):202.

PMID: 39777571 PMC: 11711572. DOI: 10.1007/s00403-024-03622-9.


The Impact of Diet on Hidradenitis Suppurativa Severity: A Cross-Sectional Case-Control Study.

Kesik F, Dogan-Gunaydin S, Fisunoglu M Medicina (Kaunas). 2025; 60(12.

PMID: 39768986 PMC: 11678350. DOI: 10.3390/medicina60122107.


Australasian hidradenitis suppurativa management guidelines.

Frew J, Smith A, Penas P, Ellis E, Foley P, Rubel D Australas J Dermatol. 2024; 66(2):75-89.

PMID: 39578415 PMC: 11898165. DOI: 10.1111/ajd.14388.


Comprehensive Codified Algorithms to Identify the Underestimated Burden of Hidradenitis Suppurativa in the United States.

Ingram J, Geissbuhler Y, Darcy 2nd J, Foley S, Gaffney A, McConnon A Dermatol Ther (Heidelb). 2024; 14(10):2859-2876.

PMID: 39316357 PMC: 11480298. DOI: 10.1007/s13555-024-01259-0.


References
1.
Adams D, Yankura J, Fogelberg A, Anderson B . Treatment of hidradenitis suppurativa with etanercept injection. Arch Dermatol. 2010; 146(5):501-4. DOI: 10.1001/archdermatol.2010.72. View

2.
Fimmel S, Zouboulis C . Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol. 2011; 2(1):9-16. PMC: 3084959. DOI: 10.4161/derm.2.1.12490. View

3.
Chen M, Odom B, Santucci R . Surgical management of genitoperineal hidradenitis suppurativa in men. Urology. 2014; 83(6):1412-7. DOI: 10.1016/j.urology.2014.01.011. View

4.
Kimball A, Sundaram M, Banderas B, Foley C, Shields A . Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa. J Dermatolog Treat. 2017; 29(2):152-164. DOI: 10.1080/09546634.2017.1341614. View

5.
Parrado R, Cadena M, Vergara A, Cadena D, Chalela J . The role of negative pressure wound therapy in the management of hidradenitis suppurativa: a case report and literature review. Int Wound J. 2015; 14(1):35-39. PMC: 7949800. DOI: 10.1111/iwj.12544. View